BackCaptor Therapeutics Spolka Akcyjna Overview

Captor Therapeutics Spolka Akcyjna EBIT

Latest ebit for CTX.WA: $-50M, below the Healthcare sector average of $1.9T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$14.57M
↓ 49.88% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$49.57M
↓ 26.8% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Captor Therapeutics Spolka Akcyjna (CTX.WA) FAQ

The latest EBIT for CTX.WA is $-50M as of June 2026. That compares with $-39M in the prior-year period — down 26.8% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside Captor Therapeutics Spolka Akcyjna's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTX.WA's EBIT moved from $-39M to $-50M — a 26.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Captor Therapeutics Spolka Akcyjna's operating scale or balance-sheet position.

Against Healthcare companies, CTX.WA currently prints $-50M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Captor Therapeutics Spolka Akcyjna's growth, margins, and balance sheet.

A EBIT figure of $-50M for CTX.WA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting CTX.WA's EBIT ($-50M), review year-over-year change from $-39M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers